• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemiol Serv Saude . COVID-19 case fatality ratio and survival among hospitalized adults in Goiás, 2020: a cohort study

tetano

Editor, Senior Moderator
Epidemiol Serv Saude


. 2025 May 23:34:e20240053.
doi: 10.1590/S2237-96222025v34e20240053.en. eCollection 2025. COVID-19 case fatality ratio and survival among hospitalized adults in Goiás, 2020: a cohort study


[Article in English, Portuguese]
Moara Alves Santa Bárbara Borges[SUP] 1 2 [/SUP], Ana Laura de Sene Amâncio Zara[SUP] 3 [/SUP], Lísia Gomes Martins de Moura Tomich[SUP] 1 4 [/SUP], Adriana Oliveira Guilarde[SUP] 1 2 [/SUP], Cacilda Pedrosa de Oliveira[SUP] 5 [/SUP], Deborah Lopes Mota Carvajal[SUP] 6 [/SUP], Marina Mascarenhas Roriz Pedrosa[SUP] 7 8 [/SUP], Paulo Sérgio Sucasas da Costa[SUP] 9 [/SUP], Marília Dalva Turchi[SUP] 1 [/SUP]



Affiliations
Abstract

in English, Spanish
Objective: To describe clinical-epidemiological and therapeutic aspects and to estimate case fatality ratio and risk factors for lower in-hospital survival due to COVID-19.
Methods: This is a retrospective cohort study conducted in the state of Goiás, Brazil, in 2020, with data obtained from the Influenza Epidemiological Surveillance Information System and through a review of clinical records and hospital. Relative risk for in-hospital death was estimated and Poisson multiple regression and Cox regression analyses were performed. Survival functions were compared using the log-rank test and represented by Kaplan-Meier curves.
Results: The sample consisted of 651 adults, whose median age was 59 years, 57.0% were admitted to public hospitals, 61.1% had severe acute respiratory syndrome on admission and 72.0% had at least one comorbidity, the most frequent being hypertension , diabetes and obesity. The overall case fatality ratio was 17.5% (95% confidence interval, 95%CI 14.7; 20.6), with no significant difference between public and private hospitals. The case fatality ratio was higher in the ≥60 years age group (prevalence ratio, PR 1.26; 95%CI 1.01; 1.58), in hypertensive patients (PR 1.41; 95%CI 1.14; 1 .74) and in those undergoing intensive care (PR 2.68; 95%CI 1.13; 6.32) and mechanical ventilation (PR 11.15; 95%CI 5.53; 22.46). The median time between hospital admission and death was 10 days (interquartile range, 6-18). Survival was lower in the ≥60 years age group (adjusted hazard ratio, HR 1.93; 95%CI 1.26; 2.95) and in those undergoing mechanical ventilation (HR 10.13; 95%CI 6.03; 17. 02).
Conclusion: Factors related to comorbidities and severity were independent predictors of shorter in-hospital survival among patients with COVID-19.


 
Back
Top Bottom